In db/db mouse models of advanced diabetes characterized by uncontrolled hyperglycemia and catabolic weight loss, PG-102 achieved superior and sustained glycemic control compared with semaglutide or tirzepatide while preserving body weight, uncoupling glycemic control from catabolic weight loss
The strategy was then applied to semaglutide, a FDA approved GLP-1 analogue, to generate hybrid 24 and we showed that not only the in vivo activity was preserved, but the stability toward pancreatin was improved opening the way for improvement in oral administration
GLP-1 RAs, by addressing both insulin resistance and adiposity, occupy a mechanistically plausible position in this interface
But if you go online today, youll find some online pharmacies already selling it even though its technically not approved for use outside of clinical trials
Its not a long-term fix, but a shorter tool to help you get started on your health journey
Cancer Immunol Res (2016) 4:2632